Comerica, Inc (CMA) concluded trading on Thursday at a closing price of $65.12, with 2.95 million shares of worth about $192.34 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.41% during that period and on January 16, 2025 the price saw a gain of about 0.05%. Currently the company’s common shares owned by public are about 132.72M shares, out of which, 130.34M shares are available for trading.
Stock saw a price change of 4.54% in past 5 days and over the past one month there was a price change of -2.19%. Year-to-date (YTD), CMA shares are showing a performance of 5.29% which increased to 22.29% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $45.32 but also hit the highest price of $73.45 during that period. The average intraday trading volume for Comerica, Inc shares is 2.21 million. The stock is currently trading 4.63% above its 20-day simple moving average (SMA20), while that difference is down -1.80% for SMA50 and it goes to 13.45% higher than SMA200.
Comerica, Inc (NYSE: CMA) currently have 132.72M outstanding shares and institutions hold larger chunk of about 86.71% of that.
The stock has a current market capitalization of $8.56B and its 3Y-monthly beta is at 1.27. PE ratio of stock for trailing 12 months is 16.27, while it has posted earnings per share of $4.00 in the same period. Its PEG reads 1.54 while making debt-to-equity ratio of 0.92. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CMA, volatility over the week remained 2.54% while standing at 2.67% over the month.
Stock’s fiscal year EPS is expected to drop by -20.73% while it is estimated to increase by 6.81% in next year. EPS is likely to grow at an annualized rate of 10.57% for next 5-years, compared to annual growth of -2.20% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on January 07, 2025 offering a Neutral rating for the stock and assigned a target price of $71 to it. On November 15, 2024, Wells Fargo Upgrade their recommendations, while on October 07, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $52. Stock get an Outperform rating from Wedbush on September 24, 2024.
